[1] SOYA S, SAKURAI T. Evolution of orexin neuropeptide system: structure and function[J]. Front Neurosci, 2020, 14. Doi: 10.3389/fnins.2020.00691.
[2] CHEN X Y, DU Y F, CHEN L. Neuropeptides exert neuroprotective effects in Alzheimer′s disease[J]. Front Mol Neurosci, 2018,11. Doi: 10.3389/fnmol.2018.00493.
[3] SHIMIZU S, TAKENOSHITA N, INAGAWA Y, et al. Positive association between cognitive function and cerebrospinal fluid orexin a levels in Alzheimer′s disease[J]. J Alzheimers Dis, 2020, 73(1): 117-123.
[4] JI M J, ZHANG X Y, CHEN Z, et al. Orexin prevents depressive-like behavior by promoting stress resilience[J]. Mol Psychiatr, 2019, 24(2): 282-293.
[5] HAN D, SHI Y, HAN F. The effects of orexin-A and orexin receptors on anxiety-and depression-related behaviors in a male rat model of post-traumatic stress disorder[J]. J Comp Neurol, 2022, 530(3): 592-606.
[6] KITAZAWA T, KAIYA H. Motilin Comparative Study: Structure, Distribution, Receptors, and Gastrointestinal Motility[J]. Front Endocrinol, 2021, 12. Doi: 10.3389/fendo.2021.700884.
[7] MIEDZYBRODZKA E L, FOREMAN R E, LU V B, et al. Stimulation of motilin secretion by bile, free fatty acids, and acidification in human duodenal organoids[J]. Mol Metab, 2021, 54. Doi: 10.1016/j.molmet.2021.101356.
[8] TACK J, VERBEURE W, MORI H, et al. The gastrointestinal tract in hunger and satiety signalling[J]. United Eur Gastroent J, 2021, 9(6): 727-734.
[9] WANG YY, LU RY, SHI J, et al. CircORC2 is involved in the pathogenesis of slow transit constipation via modulating the signalling of miR-19a and neurotensin/motilin[J]. J Cell Mol Med, 2021, 25(8): 3754-3764.
[10] YANG Z, YE S, XU Z, et al. Dietary synbiotic ameliorates constipation through the modulation of gut microbiota and its metabolic function[J]. Food Res Int, 2021, 147. Doi: 10.1016/j.foodres.2021.110569.
[11] TIAN Y, ZUO L, GUO Q, et al. Potential role of fecal microbiota in patients with constipation[J]. Ther Adv Gastroenter, 2020, 13. Doi: 10.1177/1756284820968423.
[12] REHFELD J F. Cholecystokinin and the hormone concept[J]. Endocr Connect, 2021, 10(3): R139-R150.
[13] HAN Z, BI S, XU Y, et al. Cholecystokinin expression in the development of myocardial hypertrophy[J]. Scanning, 2021, 2021. Doi: 10.1155/2021/8231559.
[14] CAWTHON C R, DE L A SERRE C B. The critical role of CCK in the regulation of food intake and diet-induced obesity[J]. Peptides, 2021, 138: 170492. Doi: 10.1016/j.peptides.2020.170492.
[15] KIM H T, DESOUZA A H, UMHOEFER H, et al. Cholecystokinin attenuates β-cell apoptosis in both mouse and human islets[J]. Transl Res, 2022, 243: 1-13. Doi: 10.1016/j.trsl.2021.10.005.
[16] AKALU Y, MOLLA M D, DESSIE G, et al. Physiological effect of ghrelin on body systems[J]. Int J Endocrinol, 2020, 2020. Doi: 10.1155/2020/1385138.
[17] ERENER T, CERITOGLU K U, AKTEKIN C N, et al. Investigation of the effect of ghrelin on bone fracture healing in rats[J]. Clin Exp Pharmacol Physiol, 2021, 48(10): 1382-1390.
[18] SATO T, OISHI K, KOGA D, et al. Thermoregulatory role of ghrelin in the induction of torpor under a restricted feeding condition[J]. Sci Rep, 2021, 11(1). Doi: 10.1038/s41598-021-97440-y.
[19] YUAN M J, LI W, ZHONG P. Research progress of ghrelin on cardiovascular disease[J]. Biosci Rep, 2021, 41(1). Doi: 10.1042/BSR20203387.
[20] STOYANOVA I, LUTZ D. Ghrelin-mediated regeneration and plasticity after nervous system injury[J]. Front Cell Dev Biol, 2021, 9. Doi: 10.3389/fcell.2021.595914.
[21] YANG C, SUN Y, OUYANG X, et al. Pain may promote tumor progression via substance P-dependent modulation of toll-like receptor-4[J]. Pain Med, 2020, 21(12): 3443-3450.
[22] LI F X, XU F, LIN X, et al. The role of substance P in the regulation of bone and cartilage metabolic activity[J]. Front Endocrinol, 2020, 11. Doi: 10.3389/fendo.2020.00077.
[23] STÖCKL S, EITNER A, BAUER R J, et al. Substance P and alpha-calcitonin gene-related peptide differentially affect human osteoarthritic and healthy chondrocytes[J]. Front Immunol, 2021, 12. Doi: 10.3389/fimmu.2021.722884.
[24] WOJCIECHOWICZ T, BILLERT M, JASASZWILI M, et al. The role of neuropeptide B and its receptors in controlling appetite, metabolism, and energy homeostasis[J]. Int J Mol Sci, 2021, 22(12). Doi: 10.3390/ijms22126632.
[25] GRZELAK T, TYSZKIEWICZ-NWAFOR M, DUTKIEWICZ A, et al. Vaspin(but not neuropeptide B or neuropeptide W) as a possible predictor of body weight normalization in anorexia nervosa[J]. Arch Med Sci, 2021, 17(2): 376-381.
[26] WOJCIECHOWICZ T, BILLERT M, DHANDAPANI P, et al. Neuropeptide B promotes proliferation and differentiation of rat brown primary preadipocytes[J]. Febs Open Bio, 2021, 11(4): 1153-1164.
[27] XING Y, LIU Y, DENG M, et al. The synergistic effects of opioid and neuropeptide B/W in rat acute inflammatory and neuropathic pain models[J]. Eur J Pharmacol, 2021, 898. Doi: 10.1016/j.ejphar.2021.173979.
[28] SHENDE P, DESAI D. Physiological and therapeutic roles of neuropeptide Y on biological functions[J]. Adv Exp Med Biol, 2020, 1237: 37-47.
[29] CHEN W C, LIU Y B, LIU W F, et al. Neuropeptide Y is an immunomodulatory factor: direct and indirect[J]. Front Immunol, 2020, 11. Doi: 10.3389/fimmu.2020.580378.
[30] MIRMAN B, IKEDA I, ZHANG Z, et al. Effects of neuropeptide Y on the microvasculature of human skeletal muscle[J]. Surgery, 2020, 168(1): 155-159.
[31] SUN W, ZHANG Z, FENG X, et al. Serum neuropeptide Y: a potential prognostic marker of intracerebral hemorrhage[J]. Dis Mark, 2021, 2021. Doi: 10.1155/2021/7957013.
[32] GENDERS S G, SCHELLER K J, DJOUMA E. Neuropeptide modulation of addiction: Focus on galanin[J]. Neurosci Biobehav Rev, 2020, 110: 133-149.
[33] FANG P, YU M, SHI M , et al. Galanin peptide family regulation of glucose metabolism[J]. Front Neuroendocrinol, 2020, 56. Doi: 10.1016/j.yfrne.2019.100801.
[34] YU M, FANG P, WANG H, et al. Beneficial effects of galanin system on diabetic peripheral neuropathic pain and its complications[J]. Peptides, 2020, 134. Doi: 10.1016/j.peptides.2020.170404.
[35] STIEDL O, KUTEEVA E, HÖKFELT T, et al. Injection of galanin into the dorsal hippocampus impairs emotional memory independent of 5-HT(1A) receptor activation[J]. Behav Brain Res, 2021, 405. Doi: 10.1016/j.bbr.2021.113178.
[36] TABIKH M, CHAHLA C, OKDEH N , et al. Parkinson disease: Protective role and function of neuropeptides[J]. Peptides, 2022, 151. Doi: 10.1016/j.peptides.2021.170713.
[37] STOJAKOVIC A, AHMAD S M, MALHOTRA S, et al. The role of pituitary adenylyl cyclase-activating polypeptide in the motivational effects of addictive drugs[J]. Neuropharmacology, 2020, 171: 108109. Doi: 10.1016/j.neuropharm.2020.108109.
[38] OJALA J, TOOKE K, HSIANG H, et al. PACAP/PAC1 Expression and Function in Micturition Pathways[J]. J Mol Neurosci, 2019, 68(3): 357-367.
[39] SZCZEPANSKA-SADOWSKA E, CUDNOCH-JEDRZEJEWSKA A, SADOWSKI B. Differential role of specific cardiovascular neuropeptides in pain regulation: Relevance to cardiovascular diseases[J]. Neuropeptides, 2020, 81: 102046. Doi: 10.1016/j.npep.2020.102046.
[40] IMANISHI A, KAWAZOE T, HAMADA Y, et al. Early detection of Niemann-pick disease type C with cataplexy and orexin levels: continuous observation with and without Miglustat[J]. Orphanet J Rare Dis, 2020, 15(1): 269. Doi: 10.1186/s13023-020-01531-4.
[41] ZHU Y, HE J, SHI J, et al. Significance of determining plasma orexin levels and analysis of related factors for the diagnosis of patients with narcolepsy[J]. Sleep Med, 2020, 74: 141-144.
[42] SKILLMAN B, KERRIGAN S. Identification of suvorexant in blood using LC-MS-MS: important considerations for matrix effects and quantitative interferences in targeted assays[J]. J Anal Toxicol, 2020, 44(3): 245-255.
[43] CHROBOK L, BAJKACZ S, KLICH J D, et al. LC-MS/MS Analysis Elucidates a Daily Rhythm in Orexin A Concentration in the Rat Vitreous Body[J]. Molecules, 2021, 26(16):. Doi: 10.3390/molecules26165036.
[44] LINDSTRÖM M, SCHINKELSHOEK M, TIENARI P J, et al. Orexin-A measurement in narcolepsy: a stability study and a comparison of LC-MS/MS and immunoassays[J]. Clin Biochem, 2021, 90: 34-39.
[45] WANG C, WANG B, AILI M, et al. Effect of Artemisia rupestris L. extract on gastrointestinal hormones and brain-gut peptides in functional dyspepsia rats[J]. Evid Based Complement Alternat Med, 2020, 2020. Doi: 10.1155/2020/2528617.
[46] MA J, MAO X, CONG H, et al. A robust composite hydrogel consisting of polypyrrole and β-cyclodextrin-based supramolecular complex for the label-free amperometricimmunodetection of motilin with well-defined dual signal response and high sensitivity[J]. Biosens Bioelectron, 2020, 173. Doi: 10.1016/j.bios.2020.112810.
[47] KAY R G, FOREMAN R E, ROBERTS G P, et al. Mass spectrometric characterisation of the circulating peptidome following oral glucose ingestion in control and gastrectomised patients[J]. Rapid Commun Mass Spectrom, 2020, 34(18). Doi: 10.1002/rcm.8849.
[48] FU J, TANG Y, ZHANG Z, et al. Gastrin exerts a protective effect against myocardial infarction via promoting angiogenesis[J]. Mol Med, 2021, 27(1). Doi: 10.1186/s10020-021-00352-w.
[49] DALY K, BURDYGA G, AL-RAMMAHI M, et al. Toll-like receptor 9 expressed in proximal intestinal enteroendocrine cells detects bacteria resulting in secretion of cholecystokinin[J]. Biochem Biophys Res Commun, 2020, 525(4): 936-940.
[50] BITARAFAN V, FITZGERALD P, LITTLE T J, et al. Effects of intraduodenal infusion of the bitter tastant, quinine, on antropyloroduodenal motility, plasma cholecystokinin, and energy intake in healthy men[J]. J Neurogastroenterol, 2019, 25(3): 413-422.
[51] MARTINEZ D V, POMRENZE M B, MANNING C E, et al. Somatodendritic release of cholecystokinin potentiates GABAergic synapses onto ventral tegmental area dopamine cells[J]. Biol Psychiatry, 2022. Doi: 10.1016/j.biopsych.2022.06.011.
[52] XIAO L, ZHANG H, WANG Y, et al. Dysregulation of the ghrelin/RANKL/OPG pathway in bone mass is related to AIS osteopenia[J]. Bone, 2020, 134. Doi: 10.1016/j.bone.2020.115291.
[53] BREITHAUPT L, CHUNGA-ITURRY N, LYALL A E, et al. Developmental stage-dependent relationships between ghrelin levels and hippocampal white matter connections in low-weight anorexia nervosa and atypical anorexia nervosa[J]. Psychoneuroendocrino, 2020, 119. Doi: 10.1016/j.psyneuen.2020.104722.
[54] O′NEILL M J, CHAN K, JAYNES J M, et al. LC-MS/MS assay coupled with carboxylic acid magnetic bead affinity capture to quantitatively measure cationic host defense peptides(HDPs) in complex matrices with application to preclinical pharmacokinetic studies[J]. J Pharm Biomed, 2020, 181. Doi: 10.1016/j.jpba.2020.113093.
[55] LANGE T, THOMAS A, WALPURGIS K , et al. Fully automated dried blood spot sample preparation enables the detection of lower molecular mass peptide and non-peptide doping agents by means of LC-HRMS[J]. Anal Bioanal Chem, 2020, 412(15): 3765-3777.
[56] THOMAS A, KROMBHOLZ S, WOLF C, et al. Determination of ghrelin and desacyl ghrelin in human plasma and urine by means of LC-MS/MS for doping controls[J]. Drug Test Anal, 2021, 13(11-12): 1862-1870.
[57] ZHONG H, HU Y, YU F. A review on ghrelin and fish reproduction[J]. Reprod Breed, 2021, 1(2): 128-135.
[58] SCHRÖDER J B, MARIAN T, CLAUS I, et al. Substance P Saliva Reduction Predicts Pharyngeal Dysphagia in Parkinson′s Disease[J]. Front Neurol, 2019, 10. Doi: 10.3389/fneur.2019.00386.
[59] RAMOS L, MASSEY CJ, ASOKAN A, et al. Examination of sex differences in a chronic rhinosinusitis surgical cohort[J]. Otolaryng Head Neck, 2022, 167(3): 583-589.
[60] BLANCO-VÁZQUEZ M, VÁZQUEZ A, FERNÁNDEZ I, et al. Inflammation-related molecules in tears of patients with chronic ocular pain and dry eye disease[J]. Exp Eye Res, 2022, 219. Doi: 10.1016/j.exer.2022.109057.
[61] FEICKERT M, BURCKHARDT B B. Validated mass spectrometric assay for the quantification of substance P and human hemokinin-1 in plasma samples: A design of experiments concept for comprehensive method development[J]. J Pharm Biomed, 2020, 191. Doi: 10.1016/j.jpba.2020.113542.
[62] FAN Y, KIM D H, GWAK Y S, et al. The role of substance P in acupuncture signal transduction and effects[J]. Brain Behav Immun, 2021, 91: 683-694.
[63] PANDEY S, TUMA Z, PERONI E, et al. Identification of NPB, NPW and their receptor in the rat heart[J]. Int J Mol Sci, 2020, 21(21). Doi: 10.1016/j.bbi.2020.08.016.
[64] KLUGE N, DACEY M, HADAYA J, et al. Rapid measurement of cardiac neuropeptide dynamics by capacitive immunoprobe in the porcine heart[J]. Am J Physiol, 2021, 320(1): H66-H76.
[65] CHAO G, WANG Z, ZHANG S. Research on correlation between psychological factors, mast cells, and PAR-2 signal pathway in irritable bowel syndrome[J]. J Inflamm Res, 2021, 14: 1427-1436.
[66] BONGAERTS J, SEGERS K, VAN OUDENHOVE L, et al. A comparative study of UniSpray and electrospray sources for the ionization of neuropeptides in liquid chromatography tandem mass spectrometry[J]. J Chromatogr A, 2020, 1628. Doi: 10.1016/j.chroma.2020.461462.
[67] SAAD K, ABDEL-RAHMAN A A, AL-ATRAM A A, et al. Serum galanin in children with autism spectrum disorder[J]. Child Psychiatry Hum Dev, 2022, 53(2): 300-306.
[68] TANRIVERDI M, KULTURSAY N, TEKGUL H, et al. Clinical value of a set of neuropeptides in term and preterm neonates with seizures: Brain derived neurotrophic factor, galanin and neuropeptide Y[J]. J Clin Neurosci, 2020, 74: 168-174.
[69] FALKENSTETTER S, LEITNER J, BRUNNER S M, et al. Galanin system in human glioma and pituitary adenoma[J]. Front Endocrinol, 2020, 11. Doi: 10.3389/fendo.2020.00155.
[70] WARFVINGE K, KRAUSE D N, MADDAHI A, et al. Estrogen receptors α, β and GPER in the CNS and trigeminal system-molecular and functional aspects[J]. J Headache Pain, 2020, 21(1). Doi: 10.1186/s10194-020-01197-0.
[71] ADAMSKA I, MALZ M, LEWCZUK B, et al. Daily profiles of neuropeptides, catecholamines, and neurotransmitter receptors in the chicken pineal gland[J]. Front Physiol, 2018, 9: 1972. Doi: 10.3389/fphys.2018.01972.
[72] EDVINSSON J, GRELL A S, WARFVINGE K, et al. Differences in pituitary adenylatecyclase-activating peptide and calcitonin gene-related peptide release in the trigeminovascularsystem[J]. Cephalalgia, 2020, 40(12): 1296-1309.
[73] KIM I, KIM Y, KANG D, et al. Neuropeptides involved in facial nerve regeneration[J]. Biomedicines, 2021, 9(11). Doi: 10.3390/biomedicines9111575.
[74] SHALASH A O, AZUAR A, MADGE H, et al. Detection and quantification of SARS-CoV-2 receptor binding domain neutralization by a sensitive competitive ELISA assay[J]. Vaccines, 2021, 9(12). Doi: 10.3390/vaccines9121493.
[75] XUE H, HAN J, HE B, et al. Bioactive peptide release and the absorption tracking of casein in the gastrointestinal digestion of rats[J]. Food Funct, 2021, 12(11): 5157-5170.
[76] CHEN F, CHENG Z, PENG Y, et al. A liquid chromatography-tandem mass spectrometry(LC-MS/MS)-based assay for simultaneous quantification of aldosterone, renin activity, and angiotensin Ⅱ in human plasma[J]. J Chromatogr B, 2021, 1179. Doi: 10.1016/j.jchromb.2021.122740.
[77] VOCAT C, DUNAND M, HUBERS S A, et al. Quantification of neuropeptide Y and four of its metabolites in human plasma by micro-UHPLC-MS/MS[J]. Anal Chem, 2020, 92(1): 859-866.
[78] LINDSTRÖM M, SCHINKELSHOEK M, TIENARI P J, et al. Orexin-A measurement in narcolepsy: A stability study and a comparison of LC-MS/MS and immunoassays[J]. Clin Biochem, 2021, 90: 34-39. Doi: 10.1016/j.clinbiochem.2021.01.009.
[79] TERRIZZI A R, MARTINEZ M P, FERNANDEZ-SOLARI J. Altered production of reproductive neuropeptides in rats subjected to chronic intermittent hypoxia[J]. J Integr Neurosci, 2021, 20(3): 651-657.
[80] MANCINI A, CURRÒ D, CIPOLLA C, et al. Evaluation of Kisspeptin levels in prepubertal obese and overweight children: sexual dimorphism and modulation of antioxidant levels[J]. Eur Rev Med Pharmacol Sci, 2021, 25(2): 941-949.
[81] RAMIREZ-VILLAFAÑA M, SALDAÑA-CRUZ A M, ACEVES-ACEVES J A, et al. Serum neuropeptide Y levels are associated with TNF-α levels and disease activity in rheumatoid arthritis[J]. J Immunol Res, 2020, 2020. Doi: 10.1155/2020/8982163.
[82] ZHANG Q, MIAO Q, YANG Y, et al. Neuropeptide Y plays an important role in the relationship between brain glucose metabolism and brown adipose tissue activity in healthy adults: a PET/CT Study[J]. Front Endocrinol, 2021, 12: 694162. Doi: 10.3389/fendo.2021.694162.
[83] FALKENSTETTER S, LEITNER J, BRUNNER S M, et al. Galanin system in human glioma and pituitary adenoma[J]. Front Endocrinol, 2020, 11. Doi: 10.3389/fendo.2020.00155.
[84] XU X, CAI X, LIU X, et al. Possible involvement of neuropeptide and neurotransmitter receptors in Adenomyosis[J]. Reprod Biol Endocrinol, 2021, 19(1). Doi: 10.1186/s12958-021-00711-6.
[85] GATENHOLM B, GOBOM J, SKILLBÄCK T, et al. Peptidomic analysis of cartilage and subchondral bone in OA patients[J]. Eur J Clin Invest, 2019, 49(5). Doi: 10.1111/eci.13082.
[86] ZHOU CX, GAO M, HAN B, et al. Quantitative peptidomics of mouse brain after infection with cyst-forming toxoplasma gondii[J]. Front Immunol, 2021, 12. Doi: 10.3389/fimmu.2021.681242.
[87] THOMAS A, YANG R, PETRING S, et al. Simplified quantification of insulin, its synthetic analogs and C-peptide in human plasma by means of LC-HRMS[J]. Drug Test Anal, 2020, 12(3): 382-390.
[88] THOMAS A, BENZENBERG L, BALLY L, et al. Facilitated qualitative determination of insulin, its synthetic analogs, and C-peptide in human urine by means of LC-HRMS[J]. Metabolites, 2021, 11(5). Doi: 10.3390/metabo11050309.
[89] KWOK K Y, CHOI T, KWOK W H, et al. Detection of bioactive peptides including gonadotrophin-releasing factors(GnRHs) in horse urine using ultra-high performance liquid chromatography-high resolution mass spectrometry(UHPLC/HRMS)[J]. Drug Test Anal, 2020, 12(9): 1274-1286.
[90] BUZY A, ALLAIN C, HARRINGTON J, et al. Peptidomics of Haemonchuscontortus[J]. ACS Omega, 2021, 6(15): 10288-10305.
[91] DOMINGO G, BENUSSI L, SARACENO C, et al. N-terminally truncated and pyroglutamate-modified Aβ forms are measurable in human cerebrospinal fluid and are potential markers of disease progression in Alzheimer′s disease[J]. Front Neurosci-Switz, 2021, 15. Doi: 10.3389/fnins.2021.708119.
[92] HUANG Y P, ROBINSON R C, DIAS F, et al. Solid-phase extraction approaches for omproving pligosaccharide and small peptide identification with liquid chromatography-high-resolution mass spectrometry: a case study on proteolyzed almond extract[J]. Foods, 2022, 11(3). Doi: 10.3390/foods11030340.
[93] DELANEY K, HU M, HELLENBRAND T, et al. Mass spectrometry quantification, localization, and discovery of feeding-related neuropeptides in cancer borealis[J]. ACS Chem Neurosci, 2021, 12(4): 782-798.
[94] SAUER C S, LI L. Mass spectrometric profiling of neuropeptides in response to copper toxicity via isobaric tagging[J]. Chem Res Toxicol, 2021, 34(5): 1329-1336.
[95] LI N, ZHOU Y, WANG J, et al. Sequential precipitation and delipidation enables efficient enrichment of low-molecular weight proteins and peptides from human plasma[J]. J Proteome Res, 2020, 19(8): 3340-3351.
[96] VU N Q, BUCHBERGER A R, JOHNSON J, et al. Complementary neuropeptide detection in crustacean brain by mass spectrometry imaging using formalin and alternative aqueous tissue washes[J]. Anal Bioanal Chem, 2021, 413(10): 2665-2673.
[97] DELANEY K, HU M, WU W, et al. Mass spectrometry profiling and quantitation of changes in circulating hormones secreted over time in cancer borealis hemolymph due to feeding behavior[J]. Anal Bioanal Chem, 2022, 414(1): 533-543.
[98] LI Z, WANG Q, MAO J, et al. Selective enrichment of N-terminal proline peptides via hydrazide chemistry for proteomics analysis[J]. Anal Chim Acta, 2021, 1142: 48-55.
[99] CHANG C H, CHANG H Y, RAPPSILBER J, et al. Isolation of acetylated and unmodified protein N-terminal peptides by strong cation exchange chromatographic separation of trypN-digested peptides[J]. Mol Cell Proteomics, 2021, 20. Doi: 10.1074/mcp.TIR120.002148.
[100]MCPHERSON R L, ONG S, LEUNG A K L. Ion-pairing with triethylammonium acetate improves solid-phase extraction of ADP-ribosylated peptides[J]. J Proteome Res, 2020, 19(2): 984-990.